%0 English Abstract
%T [Consensus on diagnosis and treatment of invasive fungal infection in patients with severe liver disease].
%A  
%A  
%A  
%A  
%J Zhonghua Gan Zang Bing Za Zhi
%V 30
%N 2
%D Feb 2022 20
%M 35359067
暂无%R 10.3760/cma.j.cn501113-20220130-00053
%X The prognosis of severe liver disease combined with invasive fungal infection (IFI) is poor, and the clinical manifestations are often atypical. Moreover, most of the antifungal drugs are metabolized in the liver, with severe toxicities and side effects, making clinical diagnosis and treatment difficult. The Professional Committee for Hepatology, the Chinese Research Hospital Association and the Hepatology Branch of China Medical Association organized relevant experts to formulate an expert consensus based on the characteristics of patients with severe liver disease combined with IFI, in order to provide reference for medical personnel in making decisions on the diagnosis and treatment.<BR>重症肝病合并侵袭性真菌感染（IFI）预后差，临床表现常不典型，而抗真菌药物又多在肝脏代谢，毒副作用大，临床诊治困难。中国研究型医院学会肝病专业委员会和中华医学会肝病学分会组织相关专家，根据重症肝病患者的特点，形成专家共识，以供医务人员在制定重症肝病合并IFI诊治决策时参考。.